BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $15.3 million in its third quarter.
On a per-share basis, the Burlingame, California-based company said it had a loss of 39 cents.
The biopharmaceutical company posted revenue of $1.1 million in the period.
Kindred Bio shares have decreased 24% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.28, a fall of 36% in the last 12 months.